ACCENDRA HEALTH INC/VA/ 10-Q

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds On February 26, 2025, our Board of Directors authorized a share repurchase program of up to $100 million through February 2027. We do not intend to make use of the authorized repurchase program. ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ (in thousands, except per share data) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ Period ​ Total Number of Shares Purchased ​ ​ Average Price Paid Per Share ​ Total Number of Shares Purchased as Part of Publicly Announced Program (1) ​ ​ Approximate Dollar Value of Shares That May Yet be Purchased Under the Program (2) February 26-February 28, 2025 ​ — ​ $ — ​ — ​ $ 100,000 March 1-March 31, 2025 ​ 173 ​ $ 8.66 ​ 173 ​ $ 98,500 April 1-April 30, 2025 ​ 653 ​ $ 7.87 ​ 653 ​ $ 93,360 May 1-May 31, 2025 ​ — ​ $ — ​ — ​ $ 93,360 June 1-June 30, 2025 ​ — ​ $ — ​ — ​ $ 93,360 July 1-July 31, 2025 ​ — ​ $ — ​ — ​ $ 93,360 August 1-August 31, 2025 ​ — ​ $ — ​ — ​ $ 93,360 September 1-September 30, 2025 ​ — ​ $ — ​ — ​ $ 93,360 October 1-October 31, 2025 ​ — ​ $ — ​ — ​ $ 93,360 November 1-November 30, 2025 ​ 1,129 ​ $ 3.10 ​ 1,129 ​ $ 89,860 December 1-December 31, 2025 ​ — ​ $ — ​ — ​ $ 89,860 January 1-January 31, 2026 ​ — ​ $ — ​ — ​ $ 89,860 February 1-February 28, 2026 ​ — ​ $ — ​ — ​ $ 89,860 March 1-March 31, 2026 ​ — ​ $ — ​ — ​ $ 89,860 April 1-April 30, 2026 ​ — ​ $ — ​ — ​ $ 89,860 May 1-May 31, 2026 ​ — ​ $ — ​ — ​ $ 89,860 June 1-June 30, 2026 ​ — ​ $ — ​ — ​ $ 89,860 Total (3) ​ 1,955 ​ ​ ​ ​ 1,955 ​ ​ ​ ​ (1) On February 26, 2025, our Board of Directors authorized a share repurchase program of up to $100 million. The program expires in February 2027. We do not intend to make use of the authorized repurchase program. (2) During the period from February 26, 2025 (the date the share repurchase program was authorized) through June 30, 2026, we repurchased shares in open-market transactions and retired approximately 2.0 million shares of our common stock for an aggregate of $10 million, or a weighted average price per share of $5.19. 34 Table of Contents (3) Represents the period from February 26, 2025 (the date the share repurchase program was authorized) through June 30, 2026.